Complications and Other Surgical Outcomes Associated with Extended Pelvic Lymphadenectomy in Men with Localized Prostate Cancer

European Urology

Volumn 50, Issue 5, 2006, Pages 1006-1013

  Briganti, Alberto ^a,b   Chun, Felix K H ^b   Salonia, Andrea ^a   Suardi, Nazareno ^a   Gallina, Andrea ^a   Da Pozzo, Luigi Filippo ^a   Roscigno, Marco ^a   Zanni, Giuseppe ^a   Valiquette, Luc ^b   Rigatti, Patrizio ^a   Montorsi, Francesco ^a   Karakiewicz, Pierre I ^b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Complications; Pelvic lymphadenectomy; Prostate cancer; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CONTROLLED STUDY; HUMAN; LENGTH OF STAY; LYMPHOCELE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SURGICAL PATIENT; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; PELVIS; POSTOPERATIVE COMPLICATIONS; PROSTATIC NEOPLASMS; ROC CURVE;

EID: 33749234029     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.08.015     Document Type: Article

References (23)

1. Aus G., Abbou C.C., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 48 (2005) 546-551
2. Bader P., Burkhard F.C., Markwalder R., and Studer U.E. Is a limited lymph node dissection an adequate staging procedure for prostate cancer?. J Urol 168 (2002) 514-518
3. Heidenreich A., Varga Z., and Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 167 (2002) 1681-1686
4. Allaf M.E., Palapattu G.S., Trock B.J., Carter H.B., and Walsh P.C. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 172 (2004) 1840-1844
5. Stone N.N., Stock R., and Unger P. Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified technique. J Urol 158 (1997) 1891-1894
6. Cheng L., Zincke H., Blute M.L., Bergstralh E.J., Scherer B., and Bostwick D.G. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 91 (2001) 66-73
7. Palapattu G.S., Allaf M.E., Trock B.J., Epstein J.I., and Walsh P.C. Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup. J Urol 172 (2004) 1860-1864
8. Bader P., Burkhard F.C., Markwalder R., and Studer U.E. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?. J Urol 169 (2003) 849-854
9. McLaughlin A.P., Saltzstein S.L., McCullough D.L., and Gittes R.F. Prostatic carcinoma: incidence and location of unsuspected lymphatic metastases. J Urol 115 (1976) 89-94
10. Clark T., Parekh D.J., Cookson M.S., Chang S.S., Smith Jr. E.R., Wells N., et al. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 169 (2003) 145-147
11. Paul D.B., Loening S.A., Narayana A.S., and Culp D.A. Morbidity from pelvic lymphadenectomy in staging carcinoma of the prostate. J Urol 129 (1983) 1141-1144
12. DiMarco D.S., Zincke H., Sebo T.J., Slezak J., Bergstralh E.J., and Blute M.L. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. J Urol 173 (2005) 1121-1125
13. Bergqvist D., Agnelli G., Cohen A.T., Eldor A., Nilsson P.E., Le Moigne-Amrani A., et al., ENOXACAN II Investigators. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 346 (2002) 975-980
14. Walsh P.C., and Donker P.J. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 128 (1982) 492-497
15. Bochner B.H., Herr H.W., and Reuter V.E. Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol 166 (2001) 2295-2296
16. Augustin H., Hammerer P., Graefen M., Palisaar J., Noldus J., Fernandez S., and Huland H. Intraoperative and perioperative morbidity of contemporary radical retropubic prostatectomy in a consecutive series of 1243 patients: results of a single center between 1999 and 2002. Eur Urol 43 (2003) 113-118
17. Herrell S.D., Trachtenberg J., and Theodorescu D. Staging pelvic lymphadenectomy for localized carcinoma of the prostate: a comparison of 3 surgical techniques. J Urol 157 (1997) 1337-1339
18. Rassweiler J., Seemann O., Schulze M., Teber D., Hatzinger M., and Frede T. Laparoscopic versus open radical prostatectomy: a comparative study at a single institution. J Urol 169 (2003) 1689-1693
19. Jeschke S., Nambirajan T., Leeb K., Ziegerhofer J., Sega W., and Janetschek G. Detection of early lymph node metastases in prostate cancer by laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 173 (2005) 1943-1946
20. McDowell II G.C., Johnson J.W., Tenney D.M., and Johnson D.E. Pelvic lymphadenectomy for staging clinically localized prostate cancer. Indications, complications, and results in 217 cases. Urology 35 (1990) 476-482
21. Pepper R.J., Pati J., and Kaisary A.V. The incidence and treatment of lymphoceles after radical retropubic prostatectomy. BJU Int 95 (2005) 772-775
22. Solberg A., Angelsen A., Bergan U., Haugen O.A., Viset T., and Klepp O. Frequency of lymphoceles after open and laparoscopic pelvic lymph node dissection in patients with prostate cancer. Scand J Urol Nephrol 37 (2003) 218-221
23. Spring D.B., Schroeder D., Babu S., Agee R., and Gooding G.A. Ultrasonic evaluation of lymphocele formation after staging lymphadenectomy for prostatic carcinoma. Radiology 141 (1981) 479-483